International Market Access Consulting (IMAC), consists of a global team of passionate individuals with decades of industry and consulting experience. Our team provides custom, high-impact, market access strategies and specialized, evidence‑based tools to effectively communicate the value of your product to key stakeholders in the payer landscape. As a specialist market access consulting company with a proven track record of success, we possess a high level of technical and scientific expertise to help our clients achieve their goals of optimized patient access for their products.
Ion Agirrezabal
Ion is an economic modeller with a background in biochemistry and statistics, a PhD in Health Economics, and 15 years across consulting and industry. He has built cost-effectiveness, budget impact models and other economic tools from scratch and led their development with external partners, across therapy areas like oncology and rare diseases and submissions to HTA agencies worldwide.
A model is only as good as the strategy and the evidence behind it, so Ion works upstream too: systematic literature reviews, indirect treatment comparisons, and real-world data analyses. He is at his best inside cross-functional teams, where clinical, statistical, and commercial thinking have to meet, and where the goal is a coherent data package that holds up in front of a payer.